
Jonathan S. Lau
Examiner (ID: 8893, Phone: (571)270-3531 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1623, 1673 |
| Total Applications | 1249 |
| Issued Applications | 700 |
| Pending Applications | 107 |
| Abandoned Applications | 463 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17297827
[patent_doc_number] => 20210393666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING ORAL MUCOSITIS
[patent_app_type] => utility
[patent_app_number] => 17/459248
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17459248
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/459248 | METHODS AND COMPOSITIONS FOR TREATING ORAL MUCOSITIS | Aug 26, 2021 | Abandoned |
Array
(
[id] => 17241946
[patent_doc_number] => 20210361689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/396989
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396989 | Bisphosphocin gel formulations and uses thereof | Aug 8, 2021 | Issued |
Array
(
[id] => 18612308
[patent_doc_number] => 20230279040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => PROCESS FOR PRODUCTION OF ASCARYLOSE AND RELATED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/007435
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007435
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007435 | Process for production of ascarylose and related compounds | Jul 29, 2021 | Issued |
Array
(
[id] => 17383877
[patent_doc_number] => 20220031729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => USE OF S-ADENOSYLMETHIONINE FOR PERSONALIZED TREATMENT OF DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/389793
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/389793 | USE OF S-ADENOSYLMETHIONINE FOR PERSONALIZED TREATMENT OF DEPRESSION | Jul 29, 2021 | Abandoned |
Array
(
[id] => 17503412
[patent_doc_number] => 20220096514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHODS OF TREATING THYMIDINE KINASE 2 DEFICIENCY BY ADMINISTERING DEOXYCYTIDINE AND DEOXYTHYMIDINE
[patent_app_type] => utility
[patent_app_number] => 17/388378
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17388378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/388378 | METHODS OF TREATING THYMIDINE KINASE 2 DEFICIENCY BY ADMINISTERING DEOXYCYTIDINE AND DEOXYTHYMIDINE | Jul 28, 2021 | Abandoned |
Array
(
[id] => 17996672
[patent_doc_number] => 11497758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Method of treating oxidative stress due to radiation exposure
[patent_app_type] => utility
[patent_app_number] => 17/378079
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3242
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378079
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378079 | Method of treating oxidative stress due to radiation exposure | Jul 15, 2021 | Issued |
Array
(
[id] => 17355358
[patent_doc_number] => 20220016154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => TREATMENT OF NEURONAL MOSAICISM IN DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 17/378626
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378626 | TREATMENT OF NEURONAL MOSAICISM IN DEMENTIA | Jul 15, 2021 | Abandoned |
Array
(
[id] => 18497367
[patent_doc_number] => 20230219990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => METHOD FOR SYNTHESIZING C-NUCLEOSIDE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/016172
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016172
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016172 | Method for synthesizing C-nucleoside compound | Jul 14, 2021 | Issued |
Array
(
[id] => 18657768
[patent_doc_number] => 20230303723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => METHOD FOR OBTAINING AN INULIN-CONTAINING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/016575
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016575
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016575 | Method for obtaining an inulin-containing composition | Jul 14, 2021 | Issued |
Array
(
[id] => 18871235
[patent_doc_number] => 11859023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 17/370920
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 8568
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/370920 | Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof | Jul 7, 2021 | Issued |
Array
(
[id] => 18582862
[patent_doc_number] => 20230265118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => SALT OF CURCUMIN MONOGLUCURONIDE
[patent_app_type] => utility
[patent_app_number] => 18/004023
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004023
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004023 | SALT OF CURCUMIN MONOGLUCURONIDE | Jul 1, 2021 | Pending |
Array
(
[id] => 18590283
[patent_doc_number] => 11739166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Reactive polysaccharide-based hemostatic agent
[patent_app_type] => utility
[patent_app_number] => 17/365749
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 41933
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365749
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365749 | Reactive polysaccharide-based hemostatic agent | Jun 30, 2021 | Issued |
Array
(
[id] => 18108012
[patent_doc_number] => 20230000892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps
[patent_app_type] => utility
[patent_app_number] => 17/364790
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17364790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/364790 | Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps | Jun 29, 2021 | Abandoned |
Array
(
[id] => 17784667
[patent_doc_number] => 11407779
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-08-09
[patent_title] => Process for the preparation of molnupiravir
[patent_app_type] => utility
[patent_app_number] => 17/362098
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2344
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17362098
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/362098 | Process for the preparation of molnupiravir | Jun 28, 2021 | Issued |
Array
(
[id] => 17625739
[patent_doc_number] => 20220160754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => DERIVATIZED CHITOSAN POLYMERS AND METHODS OF TREATING VASCULAR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/362254
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17362254
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/362254 | Derivatized chitosan polymers and methods of treating vascular disorders | Jun 28, 2021 | Issued |
Array
(
[id] => 18536011
[patent_doc_number] => 20230241098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => ANTIVIRAL PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/002666
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002666
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002666 | ANTIVIRAL PHARMACEUTICAL COMPOSITION | Jun 27, 2021 | Pending |
Array
(
[id] => 18582863
[patent_doc_number] => 20230265119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => METHOD FOR SYNTHESISING MACROMOLECULES IN SOLUTION FROM CARBOHYDRATE DERIVATIVE UNITS
[patent_app_type] => utility
[patent_app_number] => 18/012253
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 336
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18012253
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/012253 | Method for synthesizing macromolecules in solution from carbohydrate derivative units | Jun 22, 2021 | Issued |
Array
(
[id] => 19403698
[patent_doc_number] => 20240287209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => PROCESS FOR PREPARING POLYSACCHARIDE SULFATES, AND POLYSACCHARIDE SULFATE
[patent_app_type] => utility
[patent_app_number] => 18/570416
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570416 | PROCESS FOR PREPARING POLYSACCHARIDE SULFATES, AND POLYSACCHARIDE SULFATE | Jun 17, 2021 | Pending |
Array
(
[id] => 17124320
[patent_doc_number] => 20210299088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/346569
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346569
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/346569 | Method and composition for preventing and treating viral infections | Jun 13, 2021 | Issued |
Array
(
[id] => 20701426
[patent_doc_number] => 12624126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-12
[patent_title] => Dextran-alpha-glucan graft copolymers and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 17/999082
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38052
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999082 | Dextran-alpha-glucan graft copolymers and derivatives thereof | Jun 2, 2021 | Issued |